209 related articles for article (PubMed ID: 36549220)
1. Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy.
Mueller C; Elben S; Day GS; Alves P; Hebert J; Tang-Wai DF; Holtmann O; Iorio R; Perani D; Titulaer MJ; Hansen N; Bartsch T; Johnen A; Illes Z; Borm L; Willison AG; Wiendl H; Meuth SG; Kovac S; Bölte J; Melzer N
Clin Neurol Neurosurg; 2023 Jan; 224():107559. PubMed ID: 36549220
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort.
Mueller C; Langenbruch L; Rau JMH; Brix T; Strippel C; Dik A; Golombeck KS; Mönig C; Johnen A; Räuber S; Wiendl H; Meuth SG; Bölte J; Kovac S; Melzer N
Arch Clin Neuropsychol; 2022 May; 37(4):738-752. PubMed ID: 35136904
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
4. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
[TBL] [Abstract][Full Text] [Related]
5. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
Gövert F; Abrante L; Becktepe J; Balint B; Ganos C; Hofstadt-van Oy U; Krogias C; Varley J; Irani SR; Paneva S; Titulaer MJ; de Vries JM; Boon AJW; Schreurs MWJ; Joubert B; Honnorat J; Vogrig A; Ariño H; Sabater L; Dalmau J; Scotton S; Jacob S; Melzer N; Bien CG; Geis C; Lewerenz J; Prüss H; Wandinger KP; Deuschl G; Leypoldt F
Brain; 2023 Feb; 146(2):657-667. PubMed ID: 35875984
[TBL] [Abstract][Full Text] [Related]
6. Determinants of cognition in autoimmune limbic encephalitis-A retrospective cohort study.
Mueller C; Langenbruch LM; Rau JMH; Brix T; Strippel C; Dik A; Golombeck KS; Moenig C; Raeuber SJ; Kovac S; Wiendl H; Meuth SG; Bölte J; Johnen A; Melzer N
Hippocampus; 2021 Oct; 31(10):1092-1103. PubMed ID: 34270832
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
[TBL] [Abstract][Full Text] [Related]
9. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
Michael S; Waters P; Irani SR
Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
11. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
12. Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.
Ghimire P; Khanal UP; Gajurel BP; Karn R; Rajbhandari R; Paudel S; Gautam N; Ojha R
Brain Behav; 2020 Oct; 10(10):e01793. PubMed ID: 32783406
[TBL] [Abstract][Full Text] [Related]
13. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
Seery N; Butzkueven H; O'Brien TJ; Monif M
Autoimmun Rev; 2022 May; 21(5):103074. PubMed ID: 35247644
[TBL] [Abstract][Full Text] [Related]
14. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
15. Specific B- and T-cell populations are associated with cognition in patients with epilepsy and antibody positive and negative suspected limbic encephalitis.
Helmstaedter C; Hansen N; Leelaarporn P; Schwing K; Oender D; Widman G; Racz A; Surges R; Becker A; Witt JA
J Neurol; 2021 Feb; 268(2):455-466. PubMed ID: 32816110
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
Tan X; Liu Y; Wu X; Guo Y
J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
[TBL] [Abstract][Full Text] [Related]
17. Fixel-based analysis links white matter characteristics, serostatus and clinical features in limbic encephalitis.
Bauer T; Ernst L; David B; Becker AJ; Wagner J; Witt JA; Helmstaedter C; Weber B; Hattingen E; Elger CE; Surges R; Rüber T
Neuroimage Clin; 2020; 27():102289. PubMed ID: 32623136
[TBL] [Abstract][Full Text] [Related]
18. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
[TBL] [Abstract][Full Text] [Related]
19. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.
Baumgartner T; Pitsch J; Olaciregui-Dague K; Hoppe C; Racz A; Rüber T; Becker A; von Wrede R; Surges R
Epilepsia; 2022 Sep; 63(9):e100-e105. PubMed ID: 35735209
[TBL] [Abstract][Full Text] [Related]
20. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]